Akili, Inc.
AKLIDelisted Jul 2, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001850266
Akili, Inc. was delisted on Jul 2, 2024; its insiders filed their last Form 4 on Jul 8, 2024; 35 institutions reported holding it in 13F filings for Q2 2024, worth $20.4M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Akili, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 75 | 1 | 25 | −49 |
| Shares | 22.9M | 102.2K | 27.7M | +4.89M (+21.5%) |
| Value | $226.5M | $1.01M | $62.6M | −$162.9M (−72.2%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Akili, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Temasek Holdings (Private) Ltd | 11,509,122 | $26.0M | 0.16% |
| Neuberger Berman Group LLC | 5,776,884 | $13.1M | 0.01% |
| Baillie Gifford & Co | 4,665,795 | $10.5M | 0.01% |
| Suvretta Capital Management, LLC | 3,624,163 | $8.19M | 0.34% |
| Comprehensive Financial Management LLC | 1,063,422 | $2.40M | 0.06% |
| Revelation Capital Management, LLC | 245,912 | $556.0K | 13.06% |
| YHB Investment Advisors, Inc. | 92,600 | $209.0K | 0.02% |
| Perpetual Investment Management Ltd | 77,237 | $175.0K | 0.03% |
| Northeast Financial Consultants Inc | 56,554 | $128.0K | 0.01% |
| Bailard, Inc. | 38,357 | $87.0K | 0.00% |
| Susquehanna International Group, LLP | 28,289 | $64.0K | 0.00% |
| Geode Capital Management, LLC | 24,847 | $56.0K | 0.00% |
| Simplex Trading, LLC | 21,180 | $47.0K | 0.00% |
| Longitude (Cayman) Ltd. | 15,000 | $34.0K | 0.07% |
| Group One Trading, L.P. | 11,246 | $25.0K | 0.00% |
| Advisor Group Holdings, Inc. | 6,300 | $14.0K | 0.00% |
| HM Payson & Co | 715 | $2.00K | 0.00% |
| Wolverine Asset Management LLC | 895 | $2.00K | 0.00% |
Sold out (67)
Institutions that held Akili, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
Not filed for Q3 2022 yet (1)
Institutions that held Akili, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exos Asset Management LLC | 102,225 | $1.01M |